Home › Stomach Cancer › Pennsylvania › Scranton
Stomach Cancer clinical trials in Scranton, PA
3 studies for Stomach Cancer are looking for participants at sites in and around Scranton (within about 30 miles). Open a study to see who can join and how to contact the study team.
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RecruitingPhase 3
- Research Site, Wilkes-Barre · 16 mi away
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RecruitingHealthy volunteers welcome
- Geisinger Cancer Center Dickson City, Dickson City · 5 mi away
- Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi away
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Geisinger Wyoming Valley/Henry Cancer Center, Wilkes-Barre · 16 mi away
About Stomach Cancer
Did you know risk factors for stomach (gastric) cancer include a diet high in salty or smoked food or having an H. pylori infection? Learn more here.
More about Stomach Cancer on MedlinePlus
Stomach Cancer trials in other cities
- Houston, TX42 studies
- Boston, MA32 studies
- New York City, NY31 studies
- Nashville, TN28 studies
- Los Angeles, CA22 studies
- Baldwin Park, CA21 studies
- Arlington, VA20 studies
- Dallas, TX19 studies
- San Antonio, TX19 studies
- St. Louis, MO18 studies
- Grand Rapids, MI18 studies
- Washington, DC16 studies
Other studies in Scranton
- Breast Cancer6 studies
- Non-Small Cell Lung Cancer6 studies
- Lung Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Colorectal Cancer5 studies
- Prostate Cancer5 studies
- Heart Failure4 studies
- Depression3 studies
- Pancreatic Cancer3 studies
- Kidney Cancer (Renal Cell Carcinoma)3 studies
- Bladder Cancer3 studies
- Esophageal Adenocarcinoma3 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.